Previous 10 | Next 10 |
BRYAN, Texas and SAN DIEGO, Jan. 16, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody immunotherapies, announced today that Matthew P. Greving Ph.D ., its Vice President and Head of Platform Te...
2023-12-26 07:36:00 ET More on iBio iBio prices 2.25M shares at $2.00 in public offering Financial information for iBio For further details see: iBio to extend maturity date of credit facility
– Extends maturity date to March 29, 2024 – – Allows for more time to complete planned divestiture of legacy CDMO business - BRYAN, Texas and SAN DIEGO, Dec. 26, 2023 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company ...
2023-12-07 08:32:42 ET Losers: Troika Media Group TRKA -71% announces chapter 11 filing and sale to Blue Torch . Phio Pharmaceuticals Corp ( PHIO ) -48% announces exercise of warrants for $2.8 Million gross proceeds . ZyVersa Therapeutics ZVSA -46% on ...
2023-12-06 08:32:51 ET MicroAlgo ( MLGO ) +57% announced plans to establish a practice base to train graduate students for the university Pharvaris ( PHVS ) +38% surges on mid-stage success for hereditary angioedema therapy. ZyVersa Therapeutics ( ZVSA ...
2023-12-05 12:36:51 ET More on Mid-day movers stocks. Meiwu technology company limited received nasdaq delisting determination Seeking Alpha’s Quant Rating on NuZee, Inc. Historical earnings data for NuZee, Inc. Financial information for NuZee, Inc. ...
2023-12-05 08:52:03 ET More on iBio Financial information for iBio For further details see: iBio prices 2.25M shares at $2.00 in public offering
2023-12-05 08:28:55 ET Losers: Replimune Group ( REPL ) -50% presents new data from IGNYTE clinical trial of RP1 in Anti-PD1 failed Melanoma and non-Melanoma skin cancers. iBio ( IBIO ) -38% announces pricing of $4.5 Million public offering . Designer B...
BRYAN, Texas and SAN DIEGO, Dec. 05, 2023 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), today announced the pricing of its reasonable best efforts public offering of 2,250,000 of its shares of common stock (or common stock equivalents in lieu t...
2023-11-27 17:43:14 ET iBio Inc ( NYSE: IBIO ) has approved a 20-to-1 reverse split of the company’s common stock, the company said Monday. The common stock is expected to begin trading on a split-adjusted basis when the market opens on November 29, 2023, wi...
News, Short Squeeze, Breakout and More Instantly...
Strengthened cash position with investment by healthcare specialist investors Expanding into cardio-metabolic space through AstralBio collaboration BRYAN, Texas and SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company...
2024-03-28 13:35:17 ET DENVER, Colo., Mar 28, 2024 ( 247marketnews.com )- This morning’s notable listings with recent news include Trump Media & Technology Group (NASDAQ:DJT), iBio, Inc. (NYSEAMERICAN: IBIO ), Siyata Mobile (NASDAQ: SYTA ), CERo Therapeu...